HTR1A and HTR2A variants may not predict venlafaxine treatment response in China Han population with major depressive disorder

被引：5
作者：
Yuan Ruixue [1 ,3 ]
Li Xingwang [1 ,3 ]
He Guang [1 ,3 ]
Yu Tao [1 ,3 ]
Li Weidong [1 ,3 ]
Wang Lu [1 ,3 ]
Yang Fengping [1 ,3 ]
Cao Yanfei [1 ,3 ]
Wu Xi [1 ,3 ]
Niu Weibo [1 ,3 ]
Xu Fei [1 ,3 ]
Guo Zhenming [1 ,3 ]
Hu Jiaxin [1 ,3 ]
Bi Yan [1 ,3 ]
Zhu Yuhao [1 ,3 ]
Ren Decheng [1 ,3 ]
Yuan Fan [1 ,3 ]
Xu Yifeng [3 ]
He Lin [1 ,2 ,3 ]
机构：
[1] Shanghai Jiao Tong Univ, BioX Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, 1954 Huashan Rd, Shanghai 200030, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Mental Hlth, Shanghai Key Lab Psychot Disorders, 600 South Wan Ping Rd, Shanghai 200030, Peoples R China
来源：
PSYCHIATRY RESEARCH | 2018年 / 270卷
关键词：
D O I：
10.1016/j.psychres.2018.10.038
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：1179 / 1180
页数：2
相关论文
共 50 条
  • [31] Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study
    Pang, Jian-Yue
    Wang, Yi-Ping
    Teng, Hui-Min
    He, Jin
    Luo, Rui
    Feng, Si-Meng
    Yue, Wei-Hua
    Li, Heng-Fen
    [J]. BMC PSYCHIATRY, 2024, 24 (01)
  • [32] Interaction of 5-HTT and 5-HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder
    Lee, Min-Soo
    Cha, Ji-Hyun
    Chang, Hun Soo
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S82 - S82
  • [33] Association of Rare Variants in ADRA1a with Response to Treatment for Major Depressive Disorder (MDD)
    Lori, Adriana
    Tania, Carillo-Roa
    Binder, Elisabeth B.
    Mayberg, Helen S.
    McGrath, Callie L.
    Mletzko, Tanja C.
    Dunlop, Boadie W.
    Craighead, Edward W.
    Kelley, Mary E.
    Mulle, Jennifer G.
    Cubells, Joseph F.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [34] Analysis of Rare Variants in ADRA1a with Response to Treatment for Major Depressive Disorder (MDD)
    Lori, Adriana
    Carillo-Roa, Tania
    Binder, Elisabeth B.
    Mayberg, Helen S.
    McGrath, Callie L.
    Mletzko, Tanja
    Laird, Jordan L.
    Czamara, Darina
    Dunlop, Boadie W.
    Craighead, W. Edward
    Kelley, Mary E.
    Mulle, Jennifer G.
    Nemeroff, Charles B.
    Cubells, Joseph F.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 225S - 226S
  • [35] Analysis of association between common variants in the SLCO6A1 gene with schizophrenia, bipolar disorder and major depressive disorder in the Han Chinese population
    Khan, Raja Amjad Waheed
    Chen, Jianhua
    Wang, Meng
    Wen, Zujia
    Shen, Jiawei
    Song, Zhijian
    Li, Zhiqiang
    Wang, Qingzhong
    Li, Wenjin
    Xu, Yifeng
    Ji, Weidong
    Shi, Yongyong
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (02) : 140 - 146
  • [36] A preliminary association study between serotonin transporter (5-HTTLPR), receptor polymorphisms (5-HTR1A, 5-HTR2A) and depression symptom-clusters in a north Indian population suffering from Major Depressive Disorder (MDD)
    Basu, Aniruddha
    Chadda, R. K.
    Sood, Mamta
    Kaur, Harpreet
    Kukreti, Ritushree
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2019, 43 : 184 - 188
  • [37] The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population
    Zhang, Kerang
    Xu, Qi
    Xu, Yong
    Yang, Hong
    Luo, Jinxiu
    Sun, Yan
    Sun, Ning
    Wang, Shan
    Shen, Yan
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 114 (1-3) : 224 - 231
  • [38] Association between 5-HTR1A gene C-1019G polymorphism and antidepressant response in patients with major depressive disorder: A meta-analysis
    Wu, Huai-Neng
    Zhu, Shuang-Yue
    Zhang, Li-Na
    Shen, Bian-Hong
    Xu, Lian-Lian
    [J]. WORLD JOURNAL OF PSYCHIATRY, 2024, 14 (10):
  • [39] Clustering patients by depression symptoms may predict treatment outcomes for major depressive disorder: Patient-level meta-analysis of venlafaxine extended release trials
    Kato, M.
    Asami, Y.
    Boucher, M.
    Pappadopulos, E.
    Prieto Lopez, R.
    Wang, X.
    Wajsbrot, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S417 - S418
  • [40] 5-HTR2B and SLC6A3 as potential molecular targets of sertraline in the treatment of major depressive disorder: the use of bioinformatics and its practical implication
    de Oliveira, Ronaldo R.
    Kuhn, Diana
    Heidrich, Daiane
    Shansis, Flavio M.
    Ducati, Rodrigo G.
    Timmers, Luis Fernando S. M.
    [J]. NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS, 2022, 11 (01):
12345